Pharma launch plans often overlook a critical driver of success: a formal insights strategy.
Johnson & Johnson’s Medical Affairs team is transforming strategy with data-driven insights, moving beyond traditional approaches to identify key opinion leaders, improve advisory board diversity, and enhance patient journey mapping. With H1’s analytics, they are shifting from quantity to quality in engagements, advancing health equity, and leveraging AI for smarter decision-making.
In this webinar, we will share how to realize the potential of insights starts with a focus on strategy
Medical content is different from promotional content – it’s all about clinical data, real-world evidence, and scientific narratives. So, as you adopt a modular strategy for your medical content, why use a promotional approach?
In this forum, we will share traditional medical insights with the innovative world of omnichannel strategies.
This article explores how Sumitomo Pharma America (SMPA) leveraged H1’s advanced data capabilities to integrate diverse insights, enhance field medical strategies, and foster cross-functional collaboration across therapeutic areas.
Take advantage of alternative impact metrics that better reflect the multidimensional nature of today’s research dissemination and consumption.
Dig into best practices for measuring the operational effectiveness of Medical Affairs teams, emphasizing the importance of establishing a strong foundation of data and metrics to demonstrate impact and value within pharmaceutical organizations.
This virtual event discusses generating deeper discussions on the hottest topics shaping the future of Field Medical today.
Digital Science held a roundtable discussion with Medical Affairs leaders in Madrid in May 2024 on the topic of scientific communications strategies assessment and their success measurements for multiple stakeholders.